HIV-associated Kaposi's sarcoma

GPTKB entity

Predicate	Object
gptkbp:instance_of	gptkb:healthcare_organization
gptkbp:bfsLayer	5
gptkbp:bfsParent	gptkb:Pomalidomide gptkb:pomalidomide
gptkbp:affects	gptkb:skincare_product internal organs mucous membranes
gptkbp:associated_with	gptkb:HIV
gptkbp:caused_by	Kaposi's sarcoma-associated herpesvirus (KSHV)
gptkbp:characteristics	purple or brown lesions vascular proliferation lymphatic involvement
gptkbp:complications	gptkb:healthcare_organization pain bleeding lymphoedema
gptkbp:healthcare	awareness campaigns screening programs support for affected individuals education on HIV transmission
https://www.w3.org/2000/01/rdf-schema#label	HIV-associated Kaposi's sarcoma
gptkbp:is_popular_in	associated with AIDS common in sub-Saharan Africa higher in men than women
gptkbp:is_protected_by	regular health check-ups safe sex practices early HIV treatment
gptkbp:number_of_stages	advanced localized disseminated
gptkbp:research	ongoing studies on treatment efficacy clinical trials for new therapies investigations into genetic factors studies on viral load impact
gptkbp:risk_factor	male gender immunosuppression age over 50
gptkbp:social_responsibility	imaging studies biopsy more common in immunocompromised individuals associated with high-risk sexual behavior increased incidence in certain populations linked to organ transplantation
gptkbp:symptoms	HIV infection
gptkbp:treatment	gptkb:drug radiation therapy chemotherapy